Calithera Biosciencesincis A Clinical Stage Biopharmaceutical Company Based In South San Franciscocaliforniafounded In 2010The Company Specialized In The Discovery And Development Of Small Molecule Drugs Aimed At Treating Cancerits Research Focused On Tumor Metabolism And Immunologywith A Product Pipeline That Included Several Key Candidates Such As Cb 839A Glutaminase Inhibitorand Cb 280An Arginase Inhibitor Calithera Collaborated With Notable Biopharmaceutical Companies Like Incyte Corpbristol Myers Squibband Mars Symbiosciences To Advance Its Oncology Researchas Of January 2023The Company Is Operating Under A Plan Of Liquidationmarking A Transition From Its Original Focus On Precision Oncology Biopharmaceuticals
